Dermal Autologous Micrograft May Be Effective Scar Treatment

This article originally appeared here.
Share this content:
Dermal Autologous Micrograft May Be Effective Scar Treatment
Dermal Autologous Micrograft May Be Effective Scar Treatment

THURSDAY, Feb. 11, 2016 (HealthDay News) -- Treatment of exaggerated scars with dermal autologous micrografts appears effective, according to a study published online Jan. 30 in the Journal of Cosmetic Dermatology.

Fabiano Svolacchia, M.D., from Mavi Sud in Aprilia, Italy, and colleagues assessed the effectiveness of injectable dermal autologous micrografts (known as the Rigenera protocol) in the treatment of pathological scars resulting from burns, trauma, or any iatrogenic source.

The researchers observed a significant improvement in appearance and texture of the exaggerated scars in all cases following four months of autologous micrograft treatment. The micrografts are composed of mesenchymal stem cells (MSCs). Histological evaluation verified restoration of the structural layers immediately below the epidermis and a horizontal realignment of collagen fibers in the papillary dermis.

"In conclusion, although the number of reported cases is limited, we reveal the efficacy of Rigenera protocol in the management of exaggerated scars, encouraging a new therapeutic approach based on the considerable regenerative potential of the human MSCs," the authors write. "However, further studies and cases are needed to confirm this potential."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »